Cloudbyz Partners with Digital China to Expand into the Chinese Clinical Research Market

We are excited to announce that Cloudbyz has signed an important partnership with Digital China, a leading partner of digital transformation. This collaboration marks a major milestone in Cloudbyz’s mission to expand its innovative eClinical solutions into the rapidly growing China market. With this partnership, we are poised to revolutionize clinical research operations in one of the world’s most dynamic lifesciences markets, empowering life sciences companies to accelerate the development of therapies and improve patient outcomes.

Why This Partnership Matters

Entering the China market represents a significant growth opportunity for Cloudbyz. China, with its rapidly advancing healthcare infrastructure and burgeoning biotech sector, is one of the fastest-growing markets for clinical trials. However, many life sciences companies operating in the region face challenges in streamlining clinical trial processes, improving operational efficiency, and maintaining regulatory compliance. That’s where Cloudbyz comes in. 

Our partnership with Digital China will allow us to bring our cutting-edge eClinical solutions to Chinese pharmaceutical, biotech, medical device, and contract research organizations (CROs). By leveraging Cloudbyz’s unified eClinical platform, companies will be able to integrate critical clinical trial management functions such as Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Randomization and Trial Supply Management (RTSM), eTMF, and Safety & Pharmacovigilance solutions. 

Digital China’s extensive experience in China’s technology and regulatory landscapes makes them the ideal partner to guide Cloudbyz’s entry into the market. Together, we will provide life sciences companies with the tools they need to modernize their clinical trial operations and ensure that they meet local regulatory requirements while maintaining global standards of excellence.

Key Benefits of the Partnership

1. Compliance with PIPL Data Residency Requirements: Cloudbyz can ensure full compliance with PIPL’s data residency requirements by supporting local data storage within China through Salesforce on Alibaba Cloud infrastructure. Our solutions are designed to keep sensitive personal data within Chinese borders ensuring that Chinese companies meet all data localization mandates while maintaining seamless operations.

2. Improved Patient Safety and Compliance: Cloudbyz’s solutions are designed to help companies maintain the highest standards of patient safety and regulatory compliance, including adherence to the Personal Information Protection Law (PIPL) in China. Our integrated Safety & Pharmacovigilance solutions, built natively on the Salesforce platform, empower Chinese companies to manage adverse event reporting efficiently while ensuring compliance with local regulatory requirements and PIPL’s strict personal data protection mandates. Additionally, our eTMF and EDC solutions are designed to collect, store, and share clinical trial data in full compliance with both global standards and PIPL regulations, safeguarding sensitive personal information throughout the trial lifecycle.

3. Access to Local Expertise: Digital China brings over two decades of expertise in navigating China’s complex IT infrastructure, regulatory environment, and business practices. This deep local knowledge will be crucial in adapting Cloudbyz’s solutions to meet the specific needs of Chinese customers, from addressing regulatory compliance to adapting to market expectations.

4. Enhanced Operational Efficiency: China is home to some of the world’s largest clinical trials, and there is a growing demand for advanced technologies that can streamline trial operations. With Cloudbyz’s unified platform, customers in China will gain the ability to automate and integrate critical clinical trial processes, reducing administrative burden and minimizing the risk of errors. This increased efficiency will enable companies to complete trials faster and bring products to market sooner.

5. Greater Scalability and Flexibility: As Cloudbyz solutions are built on the Salesforce platform, they provide unparalleled scalability and flexibility. This partnership will enable life sciences companies in China to leverage a cloud-based system that can be customized to meet the unique needs of their clinical trials, whether they are running small-scale studies or large, multi-center trials.

6. A Strong Foundation for Growth: By partnering with Digital China, Cloudbyz is not just entering the China market—we are setting the stage for long-term growth. This collaboration will help us establish a strong foundation in the region, which will be essential as we expand our footprint and serve the growing demand for advanced eClinical solutions in the years to come.

What’s Next for Cloudbyz in China?

With the signing of this partnership, Cloudbyz is officially laying the groundwork for its expansion into the China market. Over the next several months, we will work closely with Digital China to localize our solutions for the Chinese market and begin onboarding our first customers in the region.

As part of this partnership, we will also focus on educating the market on the benefits of unified eClinical solutions. We’ll be hosting webinars, engaging with local life sciences communities, and providing demos to showcase how Cloudbyz can help companies streamline their clinical trials, ensure compliance, and improve patient safety.

Looking Ahead

The important partnership between Cloudbyz and Digital China is more than just a business venture—it represents our shared vision of transforming clinical trial operations in China and around the world. By combining Cloudbyz’s industry-leading eClinical platform with Digital China’s deep local expertise, we are confident that we can drive innovation and improve clinical research outcomes in one of the most important healthcare markets globally. As we embark on this exciting journey, we look forward to working closely with our new partners and customers in China to accelerate the delivery of life-changing therapies and bring the future of clinical trials to life.

Stay tuned for more updates as we continue to expand and innovate in the China market!

About Cloudbyz

Cloudbyz is a leading provider of unified eClinical solutions built natively on the Salesforce platform. Our platform streamlines and automates clinical trial operations, enabling life sciences companies to accelerate time to market, enhance compliance, and improve patient safety. With a global presence and an unwavering commitment to innovation, Cloudbyz is at the forefront of transforming clinical research operations.

About Digital China

Digital China Group Co., Ltd. (hereinafter called “Digital China”).Since its establishment in 2000, Digital China has been devoting to energizing digital transformation for the industry with independent innovation of core technologies and advancing great rejuvenation of the Chinese nation by digital technologies under the concept of “taking the lead in concepts, technologies & practices” . Committed to becoming a leading digital transformation partner, Digital China innovatively proposed the strategy of “Data-Cloud Fusion” and technical system framework around key elements of digital transformation. Centering on core technologies of cloud native, data native and AI native, the Company provides ubiquitous and agile IT capabilities and integrated data-driven capabilities for FMCG retail, automobile, finance, medical care, government and enterprise, education, operators and clients in other industries, builds cross-border integrated and innovative digital scenarios and new models, helps enterprise-level clients establish future-oriented core capabilities and competitive advantages, and comprehensively promotes the digital and intelligent transformation and upgrading of society.